Tag: contrave
FDA Rejects Orexigen’s New Diet Drug Over Heart Concerns
by Melly Alazraki on Feb.01, 2011, under Towing
In a surprise move Tuesday, the FDA rejected Orexigen’s proposed new diet drug Contrave, saying the company needed to run another study of its cardiovascular risks. With this rejection, all three of a slate of similar diet drugs from competing pharmaceuticals have been turned back by the agency.
Continue reading FDA Rejects Orexigen’s New Diet Drug Over Heart Concerns
FDA Rejects Orexigen’s New Diet Drug Over Heart Concerns originally appeared on DailyFinance on Tue, 01 Feb 2011 11:17:00.
Filed Under: Company News, Health Care, Stocks in the News
FDA Panel Backs Orexigen’s Diet Pill
by Melly Alazraki on Dec.07, 2010, under Towing
After the U.S. Food and Drug Administration rejected two other weight-loss pills earlier this year, an advisory panel has recommended the approval of Orexigen Therapeutics’s Contrave. If the FDA follows the recommendation, Contrave could become the first diet drug to win approval in a decade.
Continue reading FDA Panel Backs Orexigen’s Diet Pill
FDA Panel Backs Orexigen’s Diet Pill originally appeared on DailyFinance on Tue, 07 Dec 2010 20:30:00.
Filed Under: Company News, Health Care, Stocks in the News




